

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Trastuzumab-pkrb mushonga wekenza unovavarira uyo unobatsira kurapa mamwe marudzi ekenza yemazamu nedumbu. Ndizvo zvinodaidzwa nachiremba kuti monoclonal antibody, zvinoreva kuti yakagadzirirwa kuwana uye kubatanidza kune mapuroteni chaiwo pamaseru ekenza kubatsira kumisa kukura kwawo.
Mushonga uyu unopiwa kuburikidza neIV muruoko rwako kuchipatara kana nzvimbo yekupinza. Chikwata chako chehutano chichakutungamira kuburikidza nemaitiro ese, chichiona kuti unonzwa wakasununguka uye waziviswa zvakanaka nhanho imwe neimwe.
Trastuzumab-pkrb is a biosimilar version yemushonga wekutanga we trastuzumab. Funga nezvayo sekopi inenge yakafanana inoshanda nenzira imwechete asi inodhura zvishoma pane mushonga wekutanga wemhando.
Mushonga uyu ndeweboka rinonzi HER2-targeted therapies. Inoshanda nekudzivisa puroteni inonzi HER2 iyo mamwe maseru ekenza anoshandisa kukura nekupararira. Anenge 20% ekenza yemazamu uye mamwe ekenza yedumbu ane yakawanda yeiyi HER2 protein.
Mushonga uyu unouya seupfu hunosanganiswa nechikwata chako chehutano nemvura yakachena usati wakuipa kuburikidza neIV. Uchaigamuchira munzvimbo yekurapa uko nyanzvi dzakadzidziswa dzinogona kukutarisa zvakanyanya.
Trastuzumab-pkrb inorapa HER2-positive breast cancer uye HER2-positive stomach cancer. Chiremba wako achayedza maseru ako ekenza kuti ave nechokwadi chekuti ane HER2 protein usati watanga kurapwa uku.
Kwemazamu ekenza, vanachiremba vanoshandisa mushonga uyu mumamiriro akati wandei. Inogona kubatsira kuderedza bundu pamberi pekuvhiyiwa, kudzivirira kenza kubva pakudzoka mushure mekuvhiyiwa, kana kurapa kenza yakapararira kune dzimwe nhengo dzemuviri wako.
Kwemazamu ekenza, mushonga uyu unowanzo shandiswa kana kenza yapararira uye isingakwanise kubviswa nekuvhiyiwa. Inowanzo piwa pamwe chete nechemotherapy kubatsira kuita kuti kurapwa kushande zvakanyanya.
Trastuzumab-pkrb inoshanda nekunangana neprotein yeHER2 pamaseru ekenza. Inonamatira kune iyi protein semukiyi unokwana mugonhi, izvo zvinomisa maseru ekenza kubva pakugamuchira zviratidzo zvinovaudza kuti vakure uye vagovane.
Iri rinotariswa semushonga wekenza une simba repakati nepakati uyo unonyanya kunangana nemaseru ekenza panzvimbo yekukanganisa maseru ese anokurumidza kugovana mumuviri wako. Iyi nzira yakatarwa inowanzoita kuti pave nemigumisiro mishoma kana ichienzaniswa nechemotherapy yechinyakare.
Mushonga uyu unobatsirawo immune system yako kuziva nekurwisa maseru ekenza zvinobudirira. Inonyanya kumaka maseru ekenza kuitira kuti dziviriro yemuviri wako yechisikigo ikwanise kuwana nekuparadza zviri nyore.
Uchagamuchira trastuzumab-pkrb se infusion ye intravenous kuchipatara kana nzvimbo yekurapa kenza. Mushonga unopihwa kuburikidza netubhu diki rakaiswa mutsinga muruoko rwako kana kuburikidza nechiteshi kana uine chimwe.
Infusion yako yekutanga ichatora maminitsi anenge makumi mapfumbamwe, uye timu yako yehutano ichakutarisa zvakanyanya kune chero maitiro. Kana ukashivirira dose yekutanga zvakanaka, infusions yeramangwana inowanzoita maminitsi makumi matatu.
Haufaniri kudya kana kunwa chero chinhu chakakosha usati watora infusion yako. Zvisinei, zvakanaka kuti urambe wakanyatsogadzirwa nemvura uye udye chikafu chakareruka pamberi sezvo kurapwa kunogona kutora maawa mashoma kusanganisira nguva yekugadzirira.
Kureba kwekurapa kunoenderana nemamiriro ako chaiwo uye kuti unopindura sei kumushonga. Kune kenza yemazamu yekutanga, kurapwa kunowanzoita gore rimwe ne infusions mumasvondo matatu ega ega.
Kune kenza yepamberi kana metastatic, unogona kuramba uchirapwa chero zvichibatsira kudzora kenza yako uye uchishivirira zvakanaka. Chiremba wako achatarisa kufambira mberi kwako nekuongorora nguva dzose uye bvunzo dzeropa.
Usambomira kutora mushonga uyu usati wataura nachiremba wako kutanga, kunyangwe ukunzwa zviri nani. Chikwata chako chekuchengetwa kwehutano chichasarudza nguva yakanakisa yekumira zvichienderana nekupindura kwako kwega uye hutano hwese.
Kufanana nemishonga yese, trastuzumab-pkrb inogona kukonzera mhedzisiro, kunyangwe vanhu vazhinji vachizvitsungirira zvakanaka. Chinhu chakanyanya kukosha kuziva ndechekuti chikwata chako chekuchengetwa kwehutano chichakutarisa zvakanyanya uye kubatsira kubata chero nyaya dzinomuka.
Heano mhedzisiro yakajairika yaungasangana nayo panguva yekurapa:
Izvi zvinokonzeresa zvinowanzoitika uye zvinowanzoita nani sezvo muviri wako uchigadzirisa kumushonga. Chikwata chako chekuchengetwa kwehutano chine nzira dzakawanda dzekukubatsira kuti unzwe wakasununguka.
Zvimwe zvisingawanzoitiki asi zvakanyanya kukomba zvinokonzeresa zvinoda kutariswa kwekurapa nekukasira. Kunyangwe izvi zvisingaitike kune vese, zvakakosha kuziva nezvazvo:
Chiremba wako achatarisa basa remoyo wako nguva dzose panguva yekurapa sezvo mushonga uyu dzimwe nguva unogona kukanganisa kuti moyo wako unopomba sei ropa. Iyi yekutarisa inobatsira kubata chero matambudziko kare apo anonyanya kurapika.
Trastuzumab-pkrb haisi yemunhu wese, uye chiremba wako achanyatsoongorora nhoroondo yako yezvokurapa asati akuvimbisa. Chinhu chakanyanya kukosha ndechekuti bvunzo dzako dzekenza dzine protein yeHER2.
Haufanire kugamuchira mushonga uyu kana wakambove ne allergic reaction yakakomba ku trastuzumab kana chero zvinhu zvayo kare. Chiremba wako achavawo akangwarira kana uine mamwe mamiriro emoyo kana nhoroondo yematambudziko emoyo.
Vanhu vane chirwere chakakomba chemapapu kana matambudziko ekufema vangangoda kuongororwa kwakakosha kana vangave vasiri vakakodzera kurapwa uku. Chiremba wako achayera mabhenefiti achipesana nenjodzi dzemamiriro ako chaiwo.
Kana uri nepamuviri kana kuronga kuva nepamuviri, mushonga uyu unogona kukuvadza mwana wako. Chiremba wako achakurukura nzira dzinoshanda dzekudzivirira pamuviri nekukosha kwekudzivirira pamuviri panguva yekurapa uye kwemwedzi yakati wandei mushure meizvozvo.
Trastuzumab-pkrb inotengeswa pasi pezita rekuti Herzuma. Iyi ndiyo vhezheni ye biosimilar inoshanda nenzira imwechete semushonga wekutanga we trastuzumab unonzi Herceptin.
Chiremba wako kana wezve mishonga angashandisa zita re generic (trastuzumab-pkrb) kana zita remhando (Herzuma) pavanenge vachikurukura nezvekurapa kwako. Mazita ese ari maviri anoreva mushonga mumwe chete.
Inishuwarenzi inogona dzimwe nguva kusiyana pakati pemhando dzakasiyana dze trastuzumab, saka timu yako yehutano ichashanda newe kuti uwane sarudzo inodhura zvakanyanya iyo yakakodzera chirongwa chako chekurapa.
Mishonga yakati wandei inogona kurapa HER2-positive cancers, uye chiremba wako achasarudza sarudzo yakanakisa zvichienderana nemamiriro ako chaiwo. Iyo yekutanga trastuzumab (Herceptin) inoshanda nenzira imwechete se trastuzumab-pkrb.
Mamwe marapirwo anotariswa HER2 anosanganisira pertuzumab, iyo inowanzo shandiswa pamwe chete ne trastuzumab kune mamwe marudzi ekenza yemazamu. Kune zvakare T-DM1, iyo inobatanidza trastuzumab ne chemotherapy mumushonga mumwe chete.
Kune vamwe vanhu, sarudzo itsva senge tucatinib kana neratinib inogona kunge yakakodzera, kunyanya kana mamwe marapirwo asina kushanda zvakanaka. Chiremba wako weoncologist achafunga nezvezvinhu zvakaita sehutano hwako hwese, nhanho yekenza yako, uye marapirwo apfuura paanokurudzira dzimwe nzira.
Trastuzumab-pkrb inoshanda zvakanyanya seiyo yekutanga Herceptin nekuti ndizvo zvinonzi biosimilar. Izvi zvinoreva kuti zvakaratidzwa kuti zvakafanana zvakanyanya maererano nekuchengeteka uye kushanda.
Chinhu chikuru chetrastuzumab-pkrb chinowanzo chengetedza mari. Biosimilars inowanzoita mari shoma pane yekutanga brand-name mishonga, iyo inogona kubatsira kuita kuti kurapwa kuve nyore uye kuderedza mari yehutano.
Chiremba wako achafunga nezvezvinhu zvakaita se inishuwarenzi, kuwanikwa, uye zvaunofarira nzvimbo yako yekurapa paunenge uchisarudza pakati pezvisarudzo izvi. Mishonga yese miviri ichakupa iwo mabhenefiti akafanana ekurwisa kenza.
Trastuzumab-pkrb dzimwe nguva inogona kukanganisa basa remoyo, saka vanhu vane matambudziko emoyo vanoda kuongororwa zvakanyanya. Chiremba wako achaongorora basa remoyo wako nemiedzo yakaita se echocardiogram usati watanga kurapwa uye nguva dzose panguva yekurapa.
Kana uine matambudziko emoyo akapfava, unogona kunge uchiri kukwanisa kugamuchira mushonga uyu nekutarisa pedyo. Zvisinei, vanhu vane kukundikana kwemoyo kwakanyanya kana basa remoyo rakaderedzwa zvakanyanya havangave vakakodzera kurapwa uku.
Sezvo mushonga uyu uchipiwa nenyanzvi dzehutano munzvimbo yekurapa, kuwandisa kwemishonga netsaona hakusi kwakajairika. Dosing inoverengwa zvakanyatsonaka zvichienderana nehuremu hwemuviri wako uye inopiwa nevashandi vakadzidziswa.
Kana uine hanya nedosi yako kana uine zviratidzo zvisingajairiki mushure mekurapwa, taura nechikwata chako chehutano nekukasira. Vanogona kuongorora mamiriro ako uye kupa kutarisirwa kwakakodzera kana zvichidikanwa.
Kana ukakundikana kuisa infusion yakarongwa, taura nechikwata chako chehutano nekukasira kuti urongezve. Zvakakosha kuchengetedza chirongwa chako chekurapa sezvazvinogona kuitika kuti uwane mhedzisiro yakanaka.
Chiremba wako achakupa zano rekuti ungachinja sei chirongwa chako chekurapa uye kana paine shanduko kune yako dosing inodiwa. Usaedze kugadzirisa madhosi akarasika nekuronga kurapwa padyo padyo.
Usambomira kutora trastuzumab-pkrb usina kukurukura nachiremba wako kutanga. Sarudzo yekumira inoenderana nezvinhu zvakaita sekuti kenza yako iri kupindura sei, mhedzisiro yaunowana, uye chirongwa chako chekurapa.
Kwematanho ekutanga ekenza yemazamu, kurapwa kunowanzoita gore rimwe. Kune kenza yepamberi, unogona kuramba uchidaro chero mushonga uchibatsira kudzora chirwere chako uye uchichigamuchira zvakanaka.
Unogona kazhinji kugamuchira majekiseni mazhinji uchitora trastuzumab-pkrb, asi zvakakosha kuti ukurukure izvi nechikwata chako chehutano kutanga. Vanogona kukurudzira nguva yemajekiseni akapoteredza infusions yako kana kudzivirira majekiseni mhenyu panguva yekurapa.
Chiremba wako achafunga nezvemamiriro ako ega uye mamiriro ehutano hwazvino pavanenge vachigadzira mazano pamusoro pejekiseni. Izvi zvinonyanya kukosha kumajekiseni eflu yezvenguva uye majekiseni eCOVID-19.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.